Comments to FDA: OTC Drug Monograph System Share page: Docket Number: FDA-2014-N-0202 CHPA applauds and is strongly supportive of FDA's re-examination of the monograph system in an effort to complete the OTC Drug Review. Download Document Issues: OTC Medicines Monograph Reform Related Posts Press Releases and Statements CHPA Applauds Bipartisan Bill to Streamline Access to Next-Generation Sunscreens in the U.S. Jun 4, 2025 Comments Comments Regarding Amending OTC Monograph M012: Cold, Cough, Allergy, Bronchodilator, and Antiasthmatic Drug Products for Human Use May 7, 2025 Letter Letter Regarding Office of Management & Budget Request for Information: Deregulation May 12, 2025